Update your tester profile Login
  • Register with Our Database

    Get started on the volunteer process by registering your basic information with our database. This information is provided to help us determine your eligibility for current and future studies. We will not share or sell this info with any third party. 

    Thanks for your interest, you'll find the intake form here

  • College Ambassador Program

    Become a Prism Research Campus Ambassador Program and Earn Cash

     Looking for an easy way to earn extra cash this school year?

    Prism Research is recruiting Campus Ambassador’s from Colleges and Universities throughout Minnesota.  Interested?  As a Prism Campus Ambassador, all you need to do is tell your classmates and friends about upcoming studies and earn $100 for everyone you refer who successfully enrolls in a study. 

    The ideal Campus Ambassador candidate:

    •  Has screened for or enrolled in a study in the last two years.

    •  Must be enrolled for the 2016-17 academic year.

    •  Is a social media maven. You know how to leverage your Facebook, Instagram, and Twitter networks to work in your favor.

    •  Natural Promoters. You’re always talking about your favorite products and brands, whether at happy hour or in the Twittersphere.

    •  Willing to promote the Prism Brand and studies to classmates and friends.

     

    If this sounds like you or someone you know and you’re interested in finding out more about the Prism Research Campus Ambassador program, call or email Geoff Grassle, 651.641.2911 or ggrassle@prismresearchinc.com

  • Study 1613 Part 1: Healthy Female and Male Participants

     

    Research Purpose: To evaluate the safety and tolerability of an investigational drug being developed for the treatment of peanut allergy.

    Minimum Screening Qualifications:

    Males

    Men are allowed to participate

    Females

    Women who are not breastfeeding, are not pregnant or planning to become pregnant are allowed to participate.  Women on hormonal birth control are allowed to participate provided they use an approved secondary method of birth control.

    Age

    18-45 years

    Weight/Body Mass Index (BMI)

    Weight between 88 – 198 lbs. for women and between 110 – 220 lbs. for men. 

    BMI between 18-30 kg/m²

    Tobacco/Nicotine Use

    No use of tobacco/nicotine containing products including electronic cigarettes more frequently than 5 cigarettes per day prior to the study is allowed.  No tobacco/nicotine use is permitted for the duration of the study.

    Health History

    Must be healthy; not being evaluated or treated for any medical conditions unless otherwise approved on a case by case basis by the study doctor.

     

     

     

    Study Time Commitment: For participants who qualify based on screening evaluation, study participation will last for approximately 10 days

     

    Clinic Stay

    • Participants will admit to Prism Clinical Research 1 time.
    • The in Clinic stay will last approximately 4 days (3 overnights)

    Outpatient Visits

    • There is one clinic end of study visit.  

     

     

    Compensation for participation time: Up to $845.00

     

    For information regarding this study contact Andy: 651-724-8399 or andyh@prismresearchinc.com

  • Study 1613 Part 2: Healthy Female and Male Participants

     

    Research Purpose: To evaluate the safety and tolerability of an investigational drug being developed for the treatment of peanut allergy.

    Minimum Screening Qualifications: 

    Males

    Men are allowed to participate

    Females

    Women who are not breastfeeding, are not pregnant or planning to become pregnant are allowed to participate.  Women on hormonal birth control are allowed to participate provided they use an approved secondary method of birth control.

    Age

    18-45 years

    Weight/Body Mass Index (BMI)

    Weight between 88 – 198 lbs. for women and between 110 – 220 lbs. for men. 

    BMI between 18-30 kg/m²

    Tobacco/Nicotine Use

    No use of tobacco/nicotine containing products including electronic cigarettes more frequently than 5 cigarettes per day prior to the study is allowed.  No tobacco/nicotine use is permitted for the duration of the study.

    Health History

    Must be healthy; not being evaluated or treated for any medical conditions unless otherwise approved on a case by case basis by the study doctor.

     

     

     

    Study Time Commitment: For participants who qualify based on screening evaluation, study participation will last for approximately 6 weeks with 2 follow-up phone questionnaires 6 months apart.

    Clinic Stay

    • Participants will admit to Prism Clinical Research 1 time.
    • The in Clinic stay will last approximately 9 days (8 overnights)

    Outpatient Visits

    • There are 21 clinic visits following the discharge from the clinic. 
    • There will be 2 follow-up telephone questionnaires that will be performed approximately 6 months apart after completion of the clinic visits.

     

    Compensation for participation time: Up to $4095.00

     

    For information regarding this study contact Andy: 651-724-8399 or andyh@prismresearchinc.com

     

  • Non-Drug Studies

    New Non-Drug Study Opportunities Now Available Through Prism Research!

     

    Prism Research is proud to announce that we are now recruiting for non-drug studies!  You or someone you know might be qualified to participate in these studies.

     

    What are Non-Drug Studies?

    Medical devices like auto-injection pens, inhalers, and breast pumps must go through testing before they can be made available to the public.  In Non-Drug Studies, participants will simulate use of a medical device and provide feedback to how easy it was to use the device.  Just like drug-studies, participants receive financial compensation for their time

     

    Who can participate in Non-Drug Studies?

    Anyone who meets the qualifications for a specific study can participate and there will be many future opportunities.  Right now, we are specifically looking for the following people for multiple studies throughout the spring and summer:

     

    • People diagnosed with Rheumatoid Arthritis
    • Caregivers for people with Rheumatoid Arthritis

     

    Email a recuriter or call 651-289-2096 for more info!

  • Study 1610: Healthy Male and Female Participants

    Research Purpose: Study 1610 is designed to evaluate an investigational drug being developed for the treatment of select types of cancers. Participants will receive twice daily oral dose amounts for 6 days and a single dose on Day 7 of the investigational drug or placebo and one oral dose of moxifloxacin. There will be four in clinic stays of 9 days and 8 nights. The following will be  evaluated:

    • Determine the effect of the investigational drug on heart rate and electrical signals related to the heart beats
    • How quickly the body process and eliminates the investigational drug
    • The general safety/tolrability of the investigational

    Minimum Screening Qaulifications:

    Males

    Men are allowed to participate

    Females

    Women must be either post-menopausal or surgically sterile, of childbearing potential using appropriate birth-control  and who are not breast feeding or lactating are allowed to participate.

    Age

    18-55 years

    Body Mass Index (BMI)

    Between 18-32 kg/m²

    Tobacco/Nicotine Use

    No more than the equivalent of 5 cigarettes/week in the 2 months prior to screen.

    Drug Testing

    Must test negative for drugs of abuse.

    Alcohol/Drug Abuse History

    No history of drug or alcohol abuse within 1 year before the screening appointment.

    Health History

    Must be healthy; not being evaluated or treated for any medical conditions unless otherwise approved on a case by case basis by the study doctor

    Restricted Medications

    No required regular use of any prescription medications, non-prescription medications, vitamins, or herbal supplements.

     

     

     

    Study Time Commitment: For participants who qualify based on screening evaluation, study participation will last for approximately 13 weeks.

     

    In Clinic Visit Stay

    • Participants will admit to Prism Clinical Research four times for 8 overnights

    Clinic Visits

    • There is one follow-up clinic visit

     

    Compensation for participation time: Up to $8,100

    For information regarding this study contact Dayna:651-724-5047 or daynas@prismresearchinc.com

Current Studies

Contact a Recruiter

  • Register with Our Database

    Get started on the volunteer process by registering your basic information with our database. This information is provided to help us determine your eligibility for current and future studies. We will not share or sell this info with any third party. 

    Thanks for your interest, you'll find the intake form here

  • College Ambassador Program

    Become a Prism Research Campus Ambassador Program and Earn Cash

     Looking for an easy way to earn extra cash this school year?

    Prism Research is recruiting Campus Ambassador’s from Colleges and Universities throughout Minnesota.  Interested?  As a Prism Campus Ambassador, all you need to do is tell your classmates and friends about upcoming studies and earn $100 for everyone you refer who successfully enrolls in a study. 

    The ideal Campus Ambassador candidate:

    •  Has screened for or enrolled in a study in the last two years.

    •  Must be enrolled for the 2016-17 academic year.

    •  Is a social media maven. You know how to leverage your Facebook, Instagram, and Twitter networks to work in your favor.

    •  Natural Promoters. You’re always talking about your favorite products and brands, whether at happy hour or in the Twittersphere.

    •  Willing to promote the Prism Brand and studies to classmates and friends.

     

    If this sounds like you or someone you know and you’re interested in finding out more about the Prism Research Campus Ambassador program, call or email Geoff Grassle, 651.641.2911 or ggrassle@prismresearchinc.com

  • Study 1613 Part 1: Healthy Female and Male Participants

     

    Research Purpose: To evaluate the safety and tolerability of an investigational drug being developed for the treatment of peanut allergy.

    Minimum Screening Qualifications:

    Males

    Men are allowed to participate

    Females

    Women who are not breastfeeding, are not pregnant or planning to become pregnant are allowed to participate.  Women on hormonal birth control are allowed to participate provided they use an approved secondary method of birth control.

    Age

    18-45 years

    Weight/Body Mass Index (BMI)

    Weight between 88 – 198 lbs. for women and between 110 – 220 lbs. for men. 

    BMI between 18-30 kg/m²

    Tobacco/Nicotine Use

    No use of tobacco/nicotine containing products including electronic cigarettes more frequently than 5 cigarettes per day prior to the study is allowed.  No tobacco/nicotine use is permitted for the duration of the study.

    Health History

    Must be healthy; not being evaluated or treated for any medical conditions unless otherwise approved on a case by case basis by the study doctor.

     

     

     

    Study Time Commitment: For participants who qualify based on screening evaluation, study participation will last for approximately 10 days

     

    Clinic Stay

    • Participants will admit to Prism Clinical Research 1 time.
    • The in Clinic stay will last approximately 4 days (3 overnights)

    Outpatient Visits

    • There is one clinic end of study visit.  

     

     

    Compensation for participation time: Up to $845.00

     

    For information regarding this study contact Andy: 651-724-8399 or andyh@prismresearchinc.com

  • Study 1613 Part 2: Healthy Female and Male Participants

     

    Research Purpose: To evaluate the safety and tolerability of an investigational drug being developed for the treatment of peanut allergy.

    Minimum Screening Qualifications: 

    Males

    Men are allowed to participate

    Females

    Women who are not breastfeeding, are not pregnant or planning to become pregnant are allowed to participate.  Women on hormonal birth control are allowed to participate provided they use an approved secondary method of birth control.

    Age

    18-45 years

    Weight/Body Mass Index (BMI)

    Weight between 88 – 198 lbs. for women and between 110 – 220 lbs. for men. 

    BMI between 18-30 kg/m²

    Tobacco/Nicotine Use

    No use of tobacco/nicotine containing products including electronic cigarettes more frequently than 5 cigarettes per day prior to the study is allowed.  No tobacco/nicotine use is permitted for the duration of the study.

    Health History

    Must be healthy; not being evaluated or treated for any medical conditions unless otherwise approved on a case by case basis by the study doctor.

     

     

     

    Study Time Commitment: For participants who qualify based on screening evaluation, study participation will last for approximately 6 weeks with 2 follow-up phone questionnaires 6 months apart.

    Clinic Stay

    • Participants will admit to Prism Clinical Research 1 time.
    • The in Clinic stay will last approximately 9 days (8 overnights)

    Outpatient Visits

    • There are 21 clinic visits following the discharge from the clinic. 
    • There will be 2 follow-up telephone questionnaires that will be performed approximately 6 months apart after completion of the clinic visits.

     

    Compensation for participation time: Up to $4095.00

     

    For information regarding this study contact Andy: 651-724-8399 or andyh@prismresearchinc.com

     

  • Non-Drug Studies

    New Non-Drug Study Opportunities Now Available Through Prism Research!

     

    Prism Research is proud to announce that we are now recruiting for non-drug studies!  You or someone you know might be qualified to participate in these studies.

     

    What are Non-Drug Studies?

    Medical devices like auto-injection pens, inhalers, and breast pumps must go through testing before they can be made available to the public.  In Non-Drug Studies, participants will simulate use of a medical device and provide feedback to how easy it was to use the device.  Just like drug-studies, participants receive financial compensation for their time

     

    Who can participate in Non-Drug Studies?

    Anyone who meets the qualifications for a specific study can participate and there will be many future opportunities.  Right now, we are specifically looking for the following people for multiple studies throughout the spring and summer:

     

    • People diagnosed with Rheumatoid Arthritis
    • Caregivers for people with Rheumatoid Arthritis

     

    Email a recuriter or call 651-289-2096 for more info!

  • Study 1610: Healthy Male and Female Participants

    Research Purpose: Study 1610 is designed to evaluate an investigational drug being developed for the treatment of select types of cancers. Participants will receive twice daily oral dose amounts for 6 days and a single dose on Day 7 of the investigational drug or placebo and one oral dose of moxifloxacin. There will be four in clinic stays of 9 days and 8 nights. The following will be  evaluated:

    • Determine the effect of the investigational drug on heart rate and electrical signals related to the heart beats
    • How quickly the body process and eliminates the investigational drug
    • The general safety/tolrability of the investigational

    Minimum Screening Qaulifications:

    Males

    Men are allowed to participate

    Females

    Women must be either post-menopausal or surgically sterile, of childbearing potential using appropriate birth-control  and who are not breast feeding or lactating are allowed to participate.

    Age

    18-55 years

    Body Mass Index (BMI)

    Between 18-32 kg/m²

    Tobacco/Nicotine Use

    No more than the equivalent of 5 cigarettes/week in the 2 months prior to screen.

    Drug Testing

    Must test negative for drugs of abuse.

    Alcohol/Drug Abuse History

    No history of drug or alcohol abuse within 1 year before the screening appointment.

    Health History

    Must be healthy; not being evaluated or treated for any medical conditions unless otherwise approved on a case by case basis by the study doctor

    Restricted Medications

    No required regular use of any prescription medications, non-prescription medications, vitamins, or herbal supplements.

     

     

     

    Study Time Commitment: For participants who qualify based on screening evaluation, study participation will last for approximately 13 weeks.

     

    In Clinic Visit Stay

    • Participants will admit to Prism Clinical Research four times for 8 overnights

    Clinic Visits

    • There is one follow-up clinic visit

     

    Compensation for participation time: Up to $8,100

    For information regarding this study contact Dayna:651-724-5047 or daynas@prismresearchinc.com

Please provide us with your contact information (below) and will get back to you as soon as possible.

If you have a general question, check Volunteer FAQ for an answer. If you're unsure of who to contact, please visit the Contact Us page.

Cancel